Non-steroidal anti-inflammatory drug use and brain tumour risk: a case–control study within the Clinical Practice Research Datalink
- 30 August 2013
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 24 (11) , 2027-2034
Abstract
Purpose The aetiology of primary brain tumours is largely unknown; the role of non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin use and glioma risk has been inconclusive, but few population-based studies with reliable prescribing data have been conducted, and the association with meningioma risk has yet to be assessed. Methods The UK Clinical Practice Research Datalink was used to assess the association between aspirin and non-aspirin NSAID use and primary brain tumour risk using a nested case–control study design. Conditional logistic regression analysis was performed on 5,052 brain tumour patients aged 16 years and over, diagnosed between 1987 and 2009 and 42,678 controls matched on year of birth, gender and general practice, adjusting for history of allergy and hormone replacement therapy use in the glioma and meningioma models, respectively. Results In conditional logistic regression analysis, excluding drug use in the year preceding the index date, there was no association with non-aspirin NSAID use (OR 0.96, 95 % CI 0.81–1.13) or glioma risk comparing the highest category of daily defined dose to non-users; however, non-aspirin NSAID use was positively associated with meningioma risk (OR 1.35, 95 % CI 1.06–1.71). No association was seen with high- or low-dose aspirin use irrespective of histology. Conclusions This large nested case–control study finds no association between aspirin or non-aspirin NSAID use and risk of glioma but a slight increased risk with non-aspirin NSAIDs and meningioma.Keywords
This publication has 38 references indexed in Scilit:
- Cancer recording and mortality in the General Practice Research Database and linked cancer registriesPharmacoepidemiology and Drug Safety, 2012
- Nonsteroidal Anti-inflammatory Drugs and Glioma in the NIH-AARP Diet and Health Study CohortCancer Prevention Research, 2011
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor CellsCancer Research, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Effects of antihistamine and anti‐inflammatory medication use on risk of specific glioma histologiesInternational Journal of Cancer, 2010
- Epidemiology and etiology of meningiomaJournal of Neuro-Oncology, 2010
- Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cellsBiochemical and Biophysical Research Communications, 2009
- Atopy and Risk of Brain Tumors: A Meta-analysisJNCI: Journal of the National Cancer Institute, 2007
- Using prescription claims data for drugs available over‐the‐counter (OTC)Pharmacoepidemiology and Drug Safety, 2007
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005